Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
The UK has found six confirmed cases of the Brazilian COVID mutation yesterday (28 February) - but an individual who tested positive three weeks ago is still being traced throughout the country.
"By failing students, the wider economy suffers", says Lydia Jones, CEO and Founder of Housemates. Here she provides insight into how badly students have been affected by the pandemic and how the lack of government funding has negatively impacted student accommodation operators.
New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.
Germans have only taken 270,986 AstraZeneca doses so far, leaving roughly 1.17 million doses in storage across the country - but these shots are due to expire in less than six months.
The first wave saw minority ethnicities hit harder than white people, but in the second wave things are improving - with the exception of an "alarming" COVID impact in South Asians, specifically Bangladeshis and Pakistanis.
The Home Affairs Committee Chair Yvette Cooper found that 1% of the 15,000 people flying to the UK daily are being processed through the quarantine hotel system.
Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.
New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.
New documents from the FDA show that the Johnson & Johnson vaccine appears to be 86% effective against COVID-19 - signalling that it will soon be approved in the US.
According to a new study, COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death but it may increase the risk of pre-term birth.
The research team believe that some people have a genetic predisposition that increases likelihood of severe COVID, which may be crucial to understanding how mutations could change outcomes.
Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.
